Nutralife Biosciences Inc (NLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,202 | -14,675 | -4,494 | 0 | -1,053 |
| Depreciation Amortization | 800 | 642 | 65 | 0 | 239 |
| Accounts receivable | -115 | -104 | -132 | 0 | 0 |
| Accounts payable and accrued liabilities | 80 | -6 | -1 | 0 | 9 |
| Other Working Capital | 7,679 | -406 | -19 | 0 | 44 |
| Other Operating Activity | 13,880 | 13,791 | 4,091 | 0 | 171 |
| Operating Cash Flow | $-879 | $-757 | $-490 | $0 | $-590 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -110 | -30 | -20 | 0 | -16 |
| Investing Cash Flow | $-110 | $-30 | $-20 | $0 | $-16 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 0 | 235 |
| Debt Repayment | -16 | -10 | N/A | 0 | -81 |
| Common Stock Issued | 1,380 | 1,200 | 780 | 0 | 447 |
| Financing Cash Flow | $1,364 | $1,190 | $780 | $0 | $601 |
| Beginning Cash Position | 12 | 12 | 25 | 0 | 17 |
| End Cash Position | 387 | 415 | 294 | 0 | 12 |
| Net Cash Flow | $375 | $403 | $270 | $0 | $-5 |
| Free Cash Flow | |||||
| Operating Cash Flow | -879 | -757 | -490 | 0 | -590 |
| Capital Expenditure | -110 | -30 | -20 | 0 | -16 |
| Free Cash Flow | -989 | -787 | -510 | 0 | -606 |